Holen Sie sich die Stockscreener-App
12.70
1.85%
-0.24
Handel nachbörslich:
12.75
0.05
+0.39%
Schlusskurs vom Vortag:
$12.94
Offen:
$12.95
24-Stunden-Volumen:
2.79M
Relative Volume:
1.18
Marktkapitalisierung:
$2.21B
Einnahmen:
$61.10M
Nettoeinkommen (Verlust:
$-138.36M
KGV:
-9.4074
EPS:
-1.35
Netto-Cashflow:
$-90.59M
1W Leistung:
+1.44%
1M Leistung:
+2.83%
6M Leistung:
+95.38%
1J Leistung:
+50.65%
1-Tages-Spanne:
$12.41
$13.24
1-Wochen-Bereich:
$12.02
$13.24
52-Wochen-Spanne:
$5.80
$13.24
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Firmenname
Ocular Therapeutix Inc
Sektor
Branche
Telefon
781-357-4000
Adresse
15 CROSBY DRIVE, BEDFORD, MA
Vergleichen Sie OCUL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.70 | 2.21B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
| 2025-03-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-03-11 | Eingeleitet | Needham | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-20 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-02-09 | Eingeleitet | BofA Securities | Buy |
| 2023-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-10 | Fortgesetzt | Berenberg | Buy |
| 2021-08-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-11-13 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-05-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Eingeleitet | Raymond James | Strong Buy |
| 2018-09-07 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-07-12 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-08-11 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Ocular Hypertension Pipeline Insights Report DelveInsight | Santen Pharmaceutical, Nicox Ophthalmics, Inc., Allysta Pharmaceuticals, Qlaris Bio, Inc, Ripple Therapeutics, Laboratoires Thea, Ocular T - The Globe and Mail
Ocular Therapeutix stock hits 52-week high at $12.91 - Investing.com
Is Ocular Therapeutix Inc. a candidate for recovery playMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Sector ETF performance correlation with Ocular Therapeutix Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Signal strength of Ocular Therapeutix Inc. stock in tech scannersQuarterly Profit Summary & High Win Rate Trade Tips - Newser
Visual analytics tools that track Ocular Therapeutix Inc. performance2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Historical volatility pattern of Ocular Therapeutix Inc. visualizedWeekly Risk Report & Safe Entry Momentum Tips - Newser
Can Ocular Therapeutix Inc. maintain its current growth rate2025 Dividend Review & Technical Entry and Exit Tips - khodrobank.com
How to build a custom watchlist for Ocular Therapeutix Inc.Trade Ideas & Long-Term Investment Growth Plans - Newser
Statistical indicators supporting Ocular Therapeutix Inc.’s strengthQuarterly Earnings Report & High Accuracy Trade Alerts - Newser
How much upside does Ocular Therapeutix Inc. haveJuly 2025 Trade Ideas & Safe Swing Trade Setups - khodrobank.com
EURETINA Innovation Spotlight kickstarts the 2025 Congress - Modern Retina
Ocular Therapeutix Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
What are Ocular Therapeutix Inc.’s technical support levelsJuly 2025 Technicals & AI Powered Market Entry Ideas - khodrobank.com
What to do if you’re stuck in Ocular Therapeutix Inc.Quarterly Profit Report & Risk Controlled Swing Alerts - Newser
How to build a dashboard for Ocular Therapeutix Inc. stockJuly 2025 Volume & Community Verified Trade Signals - Newser
Will Ocular Therapeutix Inc. benefit from macro trends2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Will Ocular Therapeutix Inc. outperform the marketMarket Movers & High Accuracy Buy Signal Tips - Newser
Should I buy Ocular Therapeutix Inc. stock now2025 Valuation Update & Long Hold Capital Preservation Plans - khodrobank.com
Retail Surge: Can Ocular Therapeutix Inc. sustain earnings growth2025 EndofYear Setup & Short-Term Trading Alerts - خودرو بانک
Will Ocular Therapeutix Inc. bounce back from current support2025 Top Decliners & Growth Focused Stock Reports - Newser
Technical analysis overview for Ocular Therapeutix Inc. stockWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Chart based analysis of Ocular Therapeutix Inc. trendsJuly 2025 Technicals & Expert Curated Trade Setup Alerts - Newser
Best data tools to analyze Ocular Therapeutix Inc. stockJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
How hedge fund analytics apply to Ocular Therapeutix Inc. stockDollar Strength & Fast Gain Stock Trading Tips - Newser
Ocular Therapeutix Inc. Tests 50 Day MA After Sharp Decline2025 Market Sentiment & Safe Entry Zone Identification - beatles.ru
Don't Ignore The Insider Selling In Ocular Therapeutix - 富途牛牛
Ocular Therapeutix Inc. stock trend outlook and recovery pathWeekly Investment Report & Weekly Top Gainers Alerts - Newser
Visual trend scoring systems applied to Ocular Therapeutix Inc.Layoff News & Smart Investment Allocation Insights - Newser
Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ocular Therapeutix Inc-Aktie (OCUL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kaiser Peter | Chief Development Officer |
Aug 25 '25 |
Sale |
12.04 |
3,011 |
36,252 |
204,093 |
| Nayak Sanjay | Chief Strategy Officer |
Aug 25 '25 |
Sale |
12.04 |
1,885 |
22,695 |
279,738 |
| Heier Jeffrey S. | Chief Scientific Officer |
Aug 25 '25 |
Sale |
12.04 |
3,063 |
36,879 |
259,911 |
| Dugel Pravin | See Remarks |
Aug 25 '25 |
Sale |
12.04 |
21,494 |
258,788 |
3,227,244 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):